Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding


  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

TMI Blog

Home

1990 (7) TMI 222

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... per : K.S. Venkataramani, Member (T)]. Collector of Central Excise, Hyderabad has preferred these two appeals against orders No. 200/89(H) and 201/89(H) both dated 4-12-1989 passed by the Collector of Central Excise (Appeals), Madras in favour of the two respondents herein. 2. The facts in brief are that the respondents manufacture Liver Extract viz. Liver concentrate (paste and powder) .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... (Appeals) also found that the product is approved by Drug Controller and it is included in the Schedule to Drugs Price (Control) Order, 1979. 3. Appearing for the appellant Collector Shri Narasimha Murthy, learned D.R. referred to the grounds of appeal and emphasised that the product predominantly consists of solid content of liver and it is sold in bulk to other manufacturers. The product does .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ssification as held in case law reported in 1979 (4) E.L.T. 653 J. He further contended that it is for the department to prove their case for classification under Heading 30.01 which they have failed to do and on the other hand the Hyderabad Central Excise Collectorate had issued a Trade Notice 17/90 dated 7-5-1990 saying that heparin injection is a medicament classifiable under 30.03 CETA and not .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ug and not in measured doses or in retail packings. The labels of their products indicate For manufacturers use only, and are supplied to drug manufacturers and are not cleared for use in hospitals. In the circumstances, the product clearly falls outside Heading 30.03 and in such a view of the matter, the fact that the product is approved as bulk drug by Drugs Controller will not materially affe .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

 

 

 

 

Quick Updates:Latest Updates